Playback speed
10 seconds
ESMO Asia 2023 Insights: "DeLLphi-301 Study - Tarlatamab for Patients With Previously Treated SCLC"
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Myung-Ju Ahn
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Myung-Ju Ahn
162 views
January 3, 2024
Comments 0
Login to view comments.
Click here to Login